Frontiers in Endocrinology | Cancer Endocrinology

Review

Published on 08 Jun 2023

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets

in Cancer Endocrinology

Yinshuang Chen
Weipeng Wang
Maria P. Morgan
Tracy Robson
Stephanie Annett

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1148934

9,320 views
17 citations

Review

Published on 06 Jun 2023

Metabolic reprogramming of clear cell renal cell carcinoma

in Cancer Endocrinology

Haiyan Zhu
Xin Wang
Shihao Lu
Kongbo Ou

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1195500

6,258 views
16 citations

Original Research

Published on 06 Jun 2023

Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC

in Cancer Endocrinology

Wen-yu Wu
Xin Jiao
Wen-xin Song
Peng Wu
Pei-qi Xiao
Xiu-fang Huang
Kai Wang
Shao-feng Zhan

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1187882

6,541 views
8 citations

Original Research

Published on 02 Jun 2023

Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma

in Cancer Endocrinology

Ying Guo
Lili Pei
Yuzheng Li
Chunde Li
Songbai Gui
Ming Ni
Pinan Liu
Yazhuo Zhang
Liyong Zhong

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1180591

2,701 views
9 citations

Original Research

Published on 02 Jun 2023

Construction of a telomere-related gene signature to predict prognosis and immune landscape for glioma

in Cancer Endocrinology

Qin Xie
Tingting Liu
Xiaole Zhang
Yanli Ding
Xiaoyan Fan

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1145722

2,243 views
2 citations

Review

Published on 02 Jun 2023

Endocrine disrupting and carcinogenic effects of decabromodiphenyl ether

in Cancer Endocrinology

Yi Wang
Xinpei Wang
Shaofeng Sui
Zhiyan Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1183815

2,625 views
5 citations

Original Research

Published on 31 May 2023

Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha and beta testing

in Cancer Endocrinology

Anna Koot
Rosella Hermens
Petronella Ottevanger
Romana Netea-Maier
Peep Stalmeier
the COMBO study group
Marieke Snel
Noortje van der Kleij-Corssmit
Johannes Bonenkamp
Koen Dreijerink

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1162537

2,234 views
1 citation

Original Research

Published on 29 May 2023

Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications

in Cancer Endocrinology

Amirhesam Babajani
Saeed Rahmani
Masoomeh Raoufi
Elham Shaarbaf Eidgahi
Amirreza Vahid Dastjerdi
Poya Behfarnia
Shayesteh Khalili
Noushin Afshar Moghaddam

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1135196

8,561 views
5 citations

Original Research

Published on 26 May 2023

Effect of surgical treatment on patients with stage T3 or T4 triple-negative breast cancer: a SEER-based retrospective observational study

in Cancer Endocrinology

Jie Hu
Changling Dai
Yang Zhang
Weijun Chen
Lihua Sun
Xu Zhang
Minjie Duan
Hao Fu
Teng Long
Wei Kang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1184173

2,813 views

Systematic Review

Published on 26 May 2023

Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs

in Cancer Endocrinology

Eline N. M. van Vliembergen
Hidde Eijkelenkamp
Gerlof D. Valk
Menno R. Vriens
Gert J. Meijer
Martijn P. W. Intven
Joanne M. de Laat

Frontiers in Endocrinology

doi 10.3389/fendo.2023.994370

3,298 views
1 citation

Editorial

Published on 25 May 2023

Editorial: Thyroid hormone actions in cancer

in Cancer Endocrinology

Florencia Cayrol
Helena Andrea Sterle
Maria Del Mar Montesinos

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1219871

1,523 views
1 citation

Review

Published on 25 May 2023

Association between abnormal lipid metabolism and tumor

in Cancer Endocrinology

Chunyu Li
Fei Wang
Lili Cui
Shaoxin Li
Junyu Zhao
Lin Liao

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1134154

6,534 views
13 citations

Original Research

Published on 24 May 2023

Causal inference between aggressive extrathyroidal extension and survival in papillary thyroid cancer: a propensity score matching and weighting analysis

in Cancer Endocrinology

Ming Xu
Zihan Xi
Qiuyang Zhao
Wen Yang
Jie Tan
Pengfei Yi
Jun Zhou
Tao Huang

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1149826

3,317 views
4 citations

Original Research

Published on 23 May 2023

Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study

in Cancer Endocrinology

Hong Tan
Sisi Wang
Feifei Huang
Zhongyi Tong

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1138149

12,651 views
7 citations

Original Research

Published on 23 May 2023

Circulating adrenal 11-oxygenated androgens are associated with clinical outcome in endometrial cancer

in Cancer Endocrinology

Cylia Dahmani
Patrick Caron
David Simonyan
Véronique Turcotte
Jean Grégoire
Marie Plante
Chantal Guillemette

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1156680

2,409 views
3 citations

Original Research

Published on 18 May 2023

Causal associations of hyperthyroidism with prostate cancer, colon cancer, and leukemia: a Mendelian randomization study

in Cancer Endocrinology

Feipeng Xu
Zhenxin Chen

Frontiers in Endocrinology

doi 10.3389/fendo.2023.1162224

9,249 views
5 citations

Navigation group

Articles

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets

Metabolic reprogramming of clear cell renal cell carcinoma

Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC

Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma

Construction of a telomere-related gene signature to predict prognosis and immune landscape for glioma

Endocrine disrupting and carcinogenic effects of decabromodiphenyl ether

Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha and beta testing

Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications

Effect of surgical treatment on patients with stage T3 or T4 triple-negative breast cancer: a SEER-based retrospective observational study

Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs

Editorial: Thyroid hormone actions in cancer

Association between abnormal lipid metabolism and tumor

Causal inference between aggressive extrathyroidal extension and survival in papillary thyroid cancer: a propensity score matching and weighting analysis

Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study

Circulating adrenal 11-oxygenated androgens are associated with clinical outcome in endometrial cancer

Causal associations of hyperthyroidism with prostate cancer, colon cancer, and leukemia: a Mendelian randomization study